Key Record Dates
ClinicalTrials.gov Identifier: | NCT03019003 |
---|---|
Brief Title: | Oral Decitabine (ASTX727) and Durvalumab in Recurrent and/or Metastatic Head and Neck Cancer Patients |
First Submitted : | January 6, 2017 |
First Submitted that Met QC Criteria : | January 11, 2017 |
First Posted : | January 12, 2017 (Estimate) |
Last Update Submitted that Met QC Criteria : | February 17, 2023 |
Last Update Posted : | February 21, 2023 |